Diurnal fluctuation of edema synchronized with plasma VEGF concentration in a patient with POEMS syndrome

Internal Medicine

Volumn 41, Issue 12, 2002, Pages 1196-1198

  Endo, Itsuro ^a   Mitsui, Takao ^a   Nishino, Maki ^a   Oshima, Yasushi ^a   Matsumoto, Toshio ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Adrenal cortex dysfunction; Circadian rhythm; IgA ( )

Indexed keywords

CORTICOSTEROID; CORTICOTROPIN; HYPOTHALAMUS RELEASING FACTOR; IMMUNOGLOBULIN A; IMMUNOGLOBULIN LAMBDA CHAIN; LEVOTHYROXINE; M PROTEIN; VASCULOTROPIN;

ADULT; ARTICLE; BONE MARROW CELL; CASE REPORT; CIRCADIAN RHYTHM; COMPUTER ASSISTED TOMOGRAPHY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ECHOCARDIOGRAPHY; EDEMA; FEMALE; GOITER; HASHIMOTO DISEASE; HEPATOSPLENOMEGALY; HUMAN; HYPERPIGMENTATION; IMMUNOCYTOCHEMISTRY; JAPAN; LYMPHADENOPATHY; PARAAORTIC LYMPH NODE; PARAPROTEINEMIA; PARESTHESIA; PERICARDIAL EFFUSION; PLASMA CELL; PLEURA EFFUSION; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REGULATORY MECHANISM;

EID: 0036971959     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.1196     Document Type: Article

References (14)

1. Leung DW, Cachianes G, Kuang WJ, Goeddle DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 246: 1306-1309, 1989.
2. Keck PJ, Hauser SD, Krivi G, et al. Vascular permeability factor, and endotherial cell mitogen related to PDGF. Science 246: 1309-1312, 1989.
3. Watanabe O, Maruyama I, Arimura K. Over-production of vascular endothelial growth factor/vascular permeability factor is causative in Crow-Fukase (POEMS) syndrome. Muscle Nerve 21: 1390-1397, 1998.
4. Watanabe O, Arimura K, Kitajima I, Osame M, Maruyama I. Greatly raised vascular endothelial growth factor (VEGF) in POEMS syndrome . Lancet 347: 702, 1996.
5. Soubrier M, Guillon R, Dubost JJ, et al. Arterial obliteration in POEMS syndrome: Possible role of vascular endotherial growth factor. J Rheumatol 25: 813-815, 1998.
6. Nakanishi T, Sobue I, Toyokura Y, et al. The Crow-Fukase syndrome; a study of 102 cases in Japan. Neurology 34: 712-720, 1984.
7. Arimura H, Watanabe O, Arimura K, Maruyama I, Hokezu Y. Two cases of POEMS syndrome with increased vascular endotherial growth factor (VEGF). Clin Neurol Rinsho Shinkeigaku 37: 817-823, 1999.
8. Arimura K. Increased vascular endothelial growth factor (VEGF) is causative in Crow-Fukase syndrome. Clin Neurol Rinsho Shinkeigaku 39: 84-85, 1999.
9. Hashiguchi T, Arimura K, Matsumuro K, et al. Highly concentrated vascular endothelial growth factor in platelets in Crow-Fukase syndrome. Muscle Nerve 23: 1051-1056, 2000.
10. Nakano A, Mitsui T, Endo I, Takeda Y, Ozaki S, Matsumoto T. Solitary plasmacytoma with VEGF overproduction: report of a patient with polyneuropathy. Neurology 56: 818-819, 2001.
11. Petrovsky N, McNair P, Harrison LC. Diurnal rhythms of pro-inflammatory cytokines: regulation by plasma cortisol and therapeutic implications. Cytokine 10: 307-312, 1998.
12. Muc-Wierzgon M, Madej K, Baranowski M, Kokot T. Fluctuation of endogenous TNF alpha concentration in plasma in advanced cancer patients. J Biol Regul Homeost Agents 10: 25-26, 1996.
13. Liebmann PM, Reibnegger G, Lehofer M, et al. Circadian rhythm of the solbule p75 tumor necrosis factor (sTNF-R75) receptor in humans - a possible explanation for the circadian kinetics TNF-alpha effects. Int Immunol 10: 1393-1396, 1998.
14. Muc-Wierzgon M, Madej K, Boranowski M, Wierzgon J. Circadian rhythmometry of serum endogeneous tumor necrosis factor-alpha in patients with colorectal cancer metastases. Eur Cytokine Netw 9: 193-196, 1998.